Approvals/CIMA-AEMPS/SERETIDE 25 MICROGRAMOS/50 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN

Approved

STANDARD

SERETIDE 25 MICROGRAMOS/50 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5f65a8f97a209ed2
Drug Cima Aemps Name: SERETIDE 25 MICROGRAMOS/50 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN
Register Number: 9069IP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2023-10-09
Dosage Form: SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN
Dose: 25 mcg/50 mcg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

50 µg

SALMETEROL

25 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 9, 2023

Approval ID

5f65a8f97a209ed2

Type

Standard